BA
BIIB icon

Boston Advisors’s Biogen BIIB Stock Holding History

Boston Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-861
Closed -$204K – 636
2019
Q1 		$204K Sell
861
-230
-21% -$72.4K 0.01% 615
2018
Q4 		$328K Buy
1,091
+31
+3% +$9.89K 0.02% 519
2018
Q3 		$375K Sell
1,060
-590
-36% -$203K 0.02% 523
2018
Q2 		$479K Sell
1,650
-1,226
-43% -$345K 0.01% 497
2018
Q1 		$788K Buy
2,876
+11
+0.4% +$3.42K 0.02% 414
2017
Q4 		$913K Sell
2,865
-6
-0.2% -$1.93K 0.02% 378
2017
Q3 		$899K Buy
2,871
+427
+17% +$126K 0.02% 374
2017
Q2 		$663K Sell
2,444
-2,913
-54% -$770K 0.02% 434
2017
Q1 		$1.47M Sell
5,357
-102,956
-95% -$29.1M 0.03% 309
2016
Q4 		$30.7M Sell
108,313
-279
-0.3% -$82.7K 0.74% 22
2016
Q3 		$34M Sell
108,592
-18,755
-15% -$5.55M 0.84% 21
2016
Q2 		$30.8M Buy
127,347
+121,866
+2,223% +$32.1M 0.77% 26
2016
Q1 		$1.43M Sell
5,481
-1,475
-21% -$390K 0.04% 282
2015
Q4 		$2.13M Sell
6,956
-880
-11% -$253K 0.05% 257
2015
Q3 		$2.29M Sell
7,836
-20,060
-72% -$6.62M 0.09% 256
2015
Q2 		$11.3M Sell
27,896
-605
-2% -$243K 0.47% 64
2015
Q1 		$12M Buy
28,501
+1,470
+5% +$579K 0.48% 68
2014
Q4 		$9.18M Sell
27,031
-1,870
-6% -$605K 0.39% 85
2014
Q3 		$9.56M Buy
28,901
+22,835
+376% +$7.53M 0.41% 84
2014
Q2 		$1.91M Hold
6,066
– – 0.08% 217
2014
Q1 		$1.85M Buy
6,066
+89
+1% +$28.3K 0.08% 217
2013
Q4 		$1.67M Sell
5,977
-75
-1% -$19.4K 0.08% 213
2013
Q3 		$1.46M Sell
6,052
-3,164
-34% -$708K 0.08% 214
2013
Q2 		$1.98M Buy
+9,216
New +$1.97M 0.1% 180

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Advisors's BIIB Position: Q2 2019 in Review

Boston Advisors sold out of Biogen (BIIB) in Q2 2019, closing a stake of 861 shares — an estimated $204K sold.

Boston Advisors first reported a position in BIIB in Q2 2013 and held it in 24 quarters. The position peaked at $34M in Q3 2016. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Boston Advisors reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Boston Advisors sold 861 Biogen shares in Q2 2019, an estimated $204K.
  • Boston Advisors first reported a position in Biogen in Q2 2013 and held it in 24 quarters.
  • Boston Advisors's Biogen position peaked at $34M in Q3 2016.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Boston Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.